Position in BMY
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$2,811,567
-$152,398 QoQ
Shares Held
48,795
-0.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#713
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mirador Capital Partners LP holds $28,463,151 across 9 Drug Manufacturers - General names. BMY ranks #2 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
68,762 | $17,303,269 | |
| 2 | BMY |
Bristol Myers Squibb Co
This page
|
48,795 | $2,811,567 | |
| 3 | LLY |
ELI LILLY & Co
|
1,657 | $1,987,455 | |
| 4 | JNJ |
Johnson & Johnson
|
7,410 | $1,881,917 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
14,099 | $1,781,267 | |
| 6 | PFE |
Pfizer Inc
|
45,835 | $1,103,706 | |
| 7 | MRK |
Merck & Co., Inc.
|
5,882 | $755,837 | |
| 8 | AMGN |
Amgen Inc
|
1,410 | $510,589 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,811,567 | 48,795 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $2,963,965 | 48,870 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $2,581,460 | 47,858 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $2,174,045 | 48,205 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $2,252,563 | 48,662 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $2,937,644 | 48,166 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $2,678,342 | 47,354 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $2,410,049 | 46,580 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $1,927,614 | 46,415 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $2,466,597 | 45,484 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $2,236,859 | 43,595 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $2,466,061 | 42,489 | Shares | Sole | 2023-10-05 | |
| 2023-06-30 | $2,653,861 | 41,499 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,870,750 | 41,419 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $3,090,324 | 42,951 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,078,694 | 43,307 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,302,915 | 42,895 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $3,085,955 | 42,256 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $2,481,904 | 39,806 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $2,296,210 | 38,807 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $2,543,369 | 38,063 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $2,331,706 | 36,935 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $2,175,826 | 35,077 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $1,908,600 | 31,657 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,540,983 | 43,214 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $2,381,993 | 42,734 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||